Skip to main content
Top
Published in: Diabetologia 2/2011

01-02-2011 | Article

Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice

Authors: B. Valtat, C. Dupuis, D. Zenaty, A. Singh-Estivalet, F. Tronche, B. Bréant, B. Blondeau

Published in: Diabetologia | Issue 2/2011

Login to get access

Abstract

Aims/hypothesis

Prenatal exposure to excess glucocorticoids associates with low birthweight in rodents, primates and humans and its involvement in programming glucose homeostasis is suspected. Our aim was to further dissect the role of glucocorticoids on beta cell development and function in mice.

Methods

Using the model of maternal general food restriction during the last week of pregnancy, we thoroughly studied in the CD1 mouse—mothers and fetal and adult offspring—the pancreatic, metabolic and molecular consequences of maternal undernutrition associated with excess glucocorticoids. The specific involvement of the glucocorticoid receptor (GR) was studied in mutant fetuses lacking GR in pancreatic precursors or mature beta cells.

Results

Maternal general food restriction in the mouse is associated with decreased maternal glucose and increased corticosterone levels. Fetuses from underfed dams had increased corticosterone levels, decreased pancreatic endocrine gene expression but increased exocrine gene expression and a lower beta cell mass. The offspring of these dams had a low birthweight, permanent postnatal growth retardation and, as adults, impaired glucose tolerance, decreased beta cell mass (−50%) and massively reduced islet expression (−80%) of most of the genes involved in beta cell function (e.g. Pdx1, Sur1 [also known as Abcc8], insulin). Moreover, using mutant fetuses lacking GR in pancreatic precursors or beta cells we show that the deleterious effect of undernutrition on fetal beta cell development requires the presence of the GR in pancreatic precursor cells.

Conclusions/interpretation

These results demonstrate the crucial role of excess fetal glucocorticoids and the importance of GR signalling in progenitor cells to programme beta cell mass and dysfunction.
Literature
1.
go back to reference Barker DJ (1998) In utero programming of chronic disease. Clin Sci (Lond) 95:115–128CrossRef Barker DJ (1998) In utero programming of chronic disease. Clin Sci (Lond) 95:115–128CrossRef
2.
go back to reference Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019–1022CrossRefPubMed Hales CN, Barker DJ, Clark PM et al (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303:1019–1022CrossRefPubMed
3.
go back to reference Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA (1996) Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ 312:406–410PubMed Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA (1996) Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50–60 years. BMJ 312:406–410PubMed
4.
go back to reference McMillen IC, Robinson JS (2005) Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85:571–633CrossRefPubMed McMillen IC, Robinson JS (2005) Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 85:571–633CrossRefPubMed
5.
go back to reference Edwards CR, Benediktsson R, Lindsay RS, Seckl JR (1993) Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 341:355–357CrossRefPubMed Edwards CR, Benediktsson R, Lindsay RS, Seckl JR (1993) Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 341:355–357CrossRefPubMed
6.
go back to reference Cottrell EC, Seckl JR (2009) Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 3:19CrossRefPubMed Cottrell EC, Seckl JR (2009) Prenatal stress, glucocorticoids and the programming of adult disease. Front Behav Neurosci 3:19CrossRefPubMed
7.
go back to reference Reinisch JM, Simon NG, Karow WG, Gandelman R (1978) Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202:436–438CrossRefPubMed Reinisch JM, Simon NG, Karow WG, Gandelman R (1978) Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science 202:436–438CrossRefPubMed
8.
go back to reference Blondeau B, Lesage J, Czernichow P, Dupouy JP, Breant B (2001) Glucocorticoids impair fetal beta cell development in rats. Am J Physiol Endocrinol Metab 281:E592–E599PubMed Blondeau B, Lesage J, Czernichow P, Dupouy JP, Breant B (2001) Glucocorticoids impair fetal beta cell development in rats. Am J Physiol Endocrinol Metab 281:E592–E599PubMed
9.
go back to reference Lesage J, Blondeau B, Grino M, Breant B, Dupouy JP (2001) Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 142:1692–1702CrossRefPubMed Lesage J, Blondeau B, Grino M, Breant B, Dupouy JP (2001) Maternal undernutrition during late gestation induces fetal overexposure to glucocorticoids and intrauterine growth retardation, and disturbs the hypothalamo-pituitary adrenal axis in the newborn rat. Endocrinology 142:1692–1702CrossRefPubMed
10.
go back to reference Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR (1996) Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 betahydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39:1299–1305CrossRefPubMed Lindsay RS, Lindsay RM, Waddell BJ, Seckl JR (1996) Prenatal glucocorticoid exposure leads to offspring hyperglycaemia in the rat: studies with the 11 betahydroxysteroid dehydrogenase inhibitor carbenoxolone. Diabetologia 39:1299–1305CrossRefPubMed
11.
go back to reference Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR (1998) Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101:2174–2181CrossRefPubMed Nyirenda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR (1998) Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101:2174–2181CrossRefPubMed
12.
go back to reference de Vries A, Holmes MC, Heijnis A et al (2007) Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic–pituitary–adrenal axis function. J Clin Invest 117:1058–1067CrossRefPubMed de Vries A, Holmes MC, Heijnis A et al (2007) Prenatal dexamethasone exposure induces changes in nonhuman primate offspring cardiometabolic and hypothalamic–pituitary–adrenal axis function. J Clin Invest 117:1058–1067CrossRefPubMed
13.
go back to reference Nyirenda MJ, Carter R, Tang JI et al (2009) Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes 58:2873–2879CrossRefPubMed Nyirenda MJ, Carter R, Tang JI et al (2009) Prenatal programming of metabolic syndrome in the common marmoset is associated with increased expression of 11beta-hydroxysteroid dehydrogenase type 1. Diabetes 58:2873–2879CrossRefPubMed
14.
go back to reference Garofano A, Czernichow P, Breant B (1997) In utero undernutrition impairs rat beta cell development. Diabetologia 40:1231–1234CrossRefPubMed Garofano A, Czernichow P, Breant B (1997) In utero undernutrition impairs rat beta cell development. Diabetologia 40:1231–1234CrossRefPubMed
15.
go back to reference Garofano A, Czernichow P, Bréant B (1999) Effect of ageing on beta cell mass and function in rats malnourished during the perinatal period. Diabetologia 42:711–718CrossRefPubMed Garofano A, Czernichow P, Bréant B (1999) Effect of ageing on beta cell mass and function in rats malnourished during the perinatal period. Diabetologia 42:711–718CrossRefPubMed
16.
go back to reference Gesina E, Tronche F, Herrera P et al (2004) Dissecting the role of glucocorticoids on pancreas development. Diabetes 53:2322–2329CrossRefPubMed Gesina E, Tronche F, Herrera P et al (2004) Dissecting the role of glucocorticoids on pancreas development. Diabetes 53:2322–2329CrossRefPubMed
17.
go back to reference Avril I, Blondeau B, Duchene B, Czernichow P, Breant B (2002) Decreased beta cell proliferation impairs the adaptation to pregnancy in rats malnourished during perinatal life. J Endocrinol 174:215–223CrossRefPubMed Avril I, Blondeau B, Duchene B, Czernichow P, Breant B (2002) Decreased beta cell proliferation impairs the adaptation to pregnancy in rats malnourished during perinatal life. J Endocrinol 174:215–223CrossRefPubMed
18.
go back to reference Garofano A, Czernichow P, Breant B (1998) Beta cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 41:1114–1120CrossRefPubMed Garofano A, Czernichow P, Breant B (1998) Beta cell mass and proliferation following late fetal and early postnatal malnutrition in the rat. Diabetologia 41:1114–1120CrossRefPubMed
19.
go back to reference Jimenez-Chillaron JC, Hernandez-Valencia M, Reamer C et al (2005) Beta cell secretory dysfunction in the pathogenesis of low birthweight-associated diabetes: a murine model. Diabetes 54:702–711CrossRefPubMed Jimenez-Chillaron JC, Hernandez-Valencia M, Reamer C et al (2005) Beta cell secretory dysfunction in the pathogenesis of low birthweight-associated diabetes: a murine model. Diabetes 54:702–711CrossRefPubMed
20.
go back to reference Isganaitis E, Jimenez-Chillaron J, Woo M et al (2009) Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low-birthweight mice. Diabetes 58:1192–1200CrossRefPubMed Isganaitis E, Jimenez-Chillaron J, Woo M et al (2009) Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low-birthweight mice. Diabetes 58:1192–1200CrossRefPubMed
21.
go back to reference Gesina E, Blondeau B, Milet A et al (2006) Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia 49:2939–2947CrossRefPubMed Gesina E, Blondeau B, Milet A et al (2006) Glucocorticoid signalling affects pancreatic development through both direct and indirect effects. Diabetologia 49:2939–2947CrossRefPubMed
22.
go back to reference Lajic S, Nordenstrom A, Hirvikoski T (2008) Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocr Dev 13:82–98CrossRefPubMed Lajic S, Nordenstrom A, Hirvikoski T (2008) Long-term outcome of prenatal treatment of congenital adrenal hyperplasia. Endocr Dev 13:82–98CrossRefPubMed
23.
go back to reference Goto M, Piper Hanley K, Marcos J et al (2006) In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 116:953–960CrossRefPubMed Goto M, Piper Hanley K, Marcos J et al (2006) In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development. J Clin Invest 116:953–960CrossRefPubMed
24.
go back to reference Phan-Hug F, Guimiot F, Lelievre V et al (2008) Potential role of glucocorticoid signaling in the formation of pancreatic islets in the human fetus. Pediatr Res 64:346–351CrossRefPubMed Phan-Hug F, Guimiot F, Lelievre V et al (2008) Potential role of glucocorticoid signaling in the formation of pancreatic islets in the human fetus. Pediatr Res 64:346–351CrossRefPubMed
Metadata
Title
Genetic evidence of the programming of beta cell mass and function by glucocorticoids in mice
Authors
B. Valtat
C. Dupuis
D. Zenaty
A. Singh-Estivalet
F. Tronche
B. Bréant
B. Blondeau
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 2/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-1898-2

Other articles of this Issue 2/2011

Diabetologia 2/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.